World EPA Congress 2024 | Terrapinn | 11 March 2024 | Amsterdam RAI, Europaplein 24, 1078 GZ Amsterdam, Netherlands

World Leading Healthcare Evidence, Pricing and Access Congress.

2024 Speakers

Omar Ali
Visiting Lecturer, VBA & Former Advisor, NICE, University of Portsmouth

Herbert Altmann
Head of Market Access, Pricing and Reimbursement Europe, Cencora Pharmalex

Luigi Angelillo
Director, Market Access EMEA, Argenx

Ad Antonisse
Director, Market Access & External Affairs, AstraZeneca

Jose Aragunde
Value and Pricing Strategy Lead, Market Access, Novartis

Diego Ardigò
Global Rare Disease, Research & Development Head & Executive Board Member and Vice Chair, Chiesi Group & EUCOPE

Jorge Arellano
Vice President, Head of Intercontinental Markets, Market Access, Pricing, & Value Demonstration, Bristol Myers Squibb

Marnix Artz
Head Patient Access, Pricing & Governmental Affairs, Merck Group

Nico Bacharidis
Chief Commercial Officer, Cube RM

Johnny Bane
Head of Market Access, Accord Healthcare

Sylvaine Barbier
Principal, RWE & Biostatistics, Putnam

Alexander Bastian
Advisor, Market Access, A.M. Pharma & Memo Therapeutics

Dianne Baunbaek
Precision Medicine Lead, Janssen Pharmaceutical

Ahmad Bechara
Executive Vice President, Pharma, Alira Health

Tomer Ben Zaken
Head of Commercial Operations & Trade, Astellas

Katja Berg
Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU, AstraZeneca

Rito Bergemann
Vice President, Health Economics and Outcomes Research, Parexel

Nick Besseling
Manager, Value Strategies & Agreements, AstraZeneca

Ingrid Bettum
Senior Advisor, Norwegian Medicines Agency

Chris Bidad
Global Head, Access Strategy and Payer Policy, AstraZeneca

Matthias Bischof
Senior Director, Global Health Economics, Novartis Gene Therapies

Jesper Bjerggren
Associate Director, European Market Access, Teva Pharmaceuticals

Marie-Sharmila Blandino
Director, Global Access Strategy Lead, Amgen

Par Bolina
Adjunct Associate Professor, Medicinal Chemistry, Rutgers university

Thomas Bols
Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Kinga Borsos
Vice President, HEOR, Boehringer Ingelheim

Anh Bourcet (Nguyen)
Strategic Advisor, Market Access Leader, APACMed, Asia Pacific Medical Technology Association

Vidya Breeveld
Independent Market Access Expert

Jennifer Bright
President, ICHOM

Sangeeta Budhia
Vice President, Pricing & Market Access, Parexel

Robert Burley
Director, Care, Campaigns and Support, The Muscular Dystrophy U.K.

Hatice Camdere
Executive Director, Value, Access & Policy, Amgen

Gorana Capkun
Vice President, Global Head of Patient Focused Real World Evidence, Merck Group

Lorenzo Capretto
Market Access Lead EU&EM, Global Rare Disease, Chiesi Farmaceutici SpA

Sandro Cesaro
Head of Europe Market Access & Pricing, AstraZeneca

François-Xavier Chalet
Associate Director, Health Economics Expert, Idorsia Pharmaceutical Ltd.

Catherine Chamoux
Principal, AESARA

José Luis Sánchez Chorro
Director, Market Access, Spain and Portugal, Jazz Pharmaceuticals

Sally Chung
Vice President, Head of Market Access & Pricing Europe, GSK

Paolo Correale
Senior Principal, Global Pricing & Access Consulting, Eversana

Paolo Angelo Cortesi
Assistant Professor in Public Health, Research Centre on Public Health (CESP), University of Milan-Bicocca, Monza, Italy.

Elisa Crovato
Director, Pricing & Market Access, Chiesi Group

Alan Crowther
General Manager, Global Pricing & Access, Eversana

Marcus Dahlman
Head of Market Access Europe, Hansa Biopharma

Nidhi Dani
Director, Global Market Access, Novartis

Adrien De Montgolfier
Global Pricing Analyst, Ferring

Emanuele Degortes
Vice President, Global Head of Access Policy and Patient Advocacy, Menarini

Rossella Di Bidino
Head of HTA for AI Unit, Graduate School of Health Economics and Management ALTEMS

Toon Digneffe
Head, Public Affairs & Public Policy, Europe & Canada, Takeda

Riad Dirani
Vice President, Global HEOR, Medical Operations & Excellence, Teva Pharmaceuticals

Patricia Dorling
Head, Global HEOR and Real World Evidence, Chiesi Group

Ahmed Edathodu
Founding Director, Access Infinity Ltd

Ruven Remo Eul
Principal, Life Sciences, Marbls

Joanne Evason
Partner, Putnam

Gina Ewy
VP, Head of Global Market Access, Hansa Biopharma

Marina Faiella
Head, Forecasting and Business Analytics, Europe, BeiGene

Peter Fassler
Director, Market Access, Gilead Sciences

Diar Fattah
Director, Health Economics and Outcomes Research, Vertex Pharmaceuticals

Sarah Ferry
Senior Policy Advisor, Innovation & Life Sciences, NHS Confederation

Stefaan Fiers
Head of Corporate Communication, Public Affairs & Patient Advocacy, Belgium, Takeda

Lora Fleifel
Director, Market Access Operations, Oncology Europe, Merck

Graham Foxon
Managing Director, Remap Consulting

Neil Gallagher
Managing Economist, Copenhagen Economics

Benjamin Gannon
Vice President, International, Guardant Health

Sonia García Pérez
HTACG representative. Head of international affairs., AEMPS

Suzanne Gaunt
Chief Executive Officer, Your Advisor

Alexander Gee
Senior Director, Customer Strategy, Parexel

Fabrizio Gianfrate
Full Professor, Health Economics and Outcomes Research, Former AIFA

Jonathan Gibson
Market Access Consultant, Initiate Consultancy

Ramiro Gilardino
Senior Director, Global HTA & Access Policy Lead, MSD

Thomas Gilboy
Product Owner, Access Infinity

Christoph Glaetzer
Chief Global Value and Access Officer, Johnson & Johnson

Tristan Gloede
Executive Director, Global Head of Market Access Retinal Health, Boehringer Ingelheim

Josie Godfrey
Co-Chief Executive Officer, Realise Advocacy

Maja Graf
Associate Director, Policy & Market Access, Medicines for Europe

Ingolf Griebsch
Global Head, Health Economics & Outcome Research, Ferring Pharmaceuticals

Thomas Grub
Senior Expert, Global Pricing and Market Access, medac GmbH

Neil Grubert
Global Market Access Consultant, Independent

Josep Maria Guiu Segura
Director, Pharmacy and Medicines Area, Consortium of health and social care of Catalonia

Marlene Gyldmark
Head Access Evidence, Idorsia

Janice Haigh
Practice Lead, Remap Consulting

Matthew Hanchard
Research Fellow, University of Sheffield

Günter Harms
Senior Director, Patient Access, Germany, Austria, Switzerland, Novartis Gene Therapies

Adrian Harrington
Senior Director, Value & Access, Biogen

Hugo Hayes
Manager, Putnam

Alison Horsfield
Director, Global Access Strategy, Astrazeneca

Kirsty Hoyle
CEO, Metabolic Support UK

Tijana Ignjatovic
Executive Director, Genesis Research Group

Giorgio Iotti
Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Dawn Ireland
President & Founder, CDH International

Khalid Ismail
Senior Manager, Market Access Benelux, CSL Behring

Shrividya Iyer
Principal, Putnam Associates

Jayasree Iyer
Chief Executive Officer, Access to Medicine Foundation

Daniel Jackson
Global Head, Market Access Policy, UCB

Saira Jan
Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Rosemary Jose
Executive Director, Market Access & HEOR, OPEN Health

Madhu Kabra
Global Director, Health Economics and Outcomes Research, MKGlobal

Lisette Kaskens
Director, Market Access, Europe, LATAM & Canada, Ferring Pharmaceuticals

Sebastian Kessel
Senior Director, Head of Market Access & External Engagement Germany, UCB

Rob Kettell
Director, Commercial Medicines Negotiation and Complex Transactions, NHS England

Elizabeth Kinter
Vice President, Head of Evidence, Value and Access, Vir Biotechnology

Sandeep Kiri
Global Head, Health Economics and HTA Evidence, Ucb

Lori Klein
Partner, Medical & Scientific Affairs Practice Lead, Putnam

Jolanda Koenders
Head of New Product Planning, Central Southeast Europe, Takeda

Hannah Kurth
Founder, PULSEdge

Lydia Lanman
Director, Global Policy, Roche

Marianne Laouri
Executive Director, Value Demonstration, Specialty Products & Quality of Care, Boehringer Ingelheim

Agathe Le Lay
Vice President, Head of Global Value Evidence & Patient Insights, Medical Affairs, H. Lundbeck A/S

Colombe Le Rudulier
Senior Consultant, Life Sciences, Marbls

Katja Lundell
Senior Director, Global Head of Pricing, Access and Communications, theramex

Elena Lungu
Manager of Policy Development, Patented Medicine Prices Review Board, Government of Canada

Manuela Machado
Head, Global Payer Strategy Solutions, Ucb

Jörg Mahlich
Market Access and Government Affairs Lead, Milteny

Charles Makin
Head, RWE and Epi, Boehringer Ingelheim

Farzana Malik
Independent Market Access Expert

Chris Mancill
Senior Vice President, Head, Global Market Access, Pricing, and Value Demonstration, Bristol Myers Squibb

Lorenzo Mantovani
Professor of Public Health, University Of Milano - Bicocca

Andrea Mantovani
VP & Partner, Consulting (Value, Access & Pricing), Alira Health

Anne Marciniak
Market Access and Health Economics Executive, Adelphi Values

Silvy Mardiguian
Senior Director, Head of HEOR, Europe & New Markets, BeiGene

Francesco Marinucci
Director, Global Market Access, Abbott

Jake McDowell
Vice President, Head of Market Access and Pricing, Partner Therapeutics

Vivian Mendonca
Senior Vice President, Global Head, Market Access, Pricing, HEOR and External Affairs, MENARINI GROUP

Magnus Meyer
Global Pricing & Market Access Manager, Lundbeck

Erin Mistry
Executive Vice President, Chief Commercial Officer, CorMedix Inc

Leyla Mohseninejad
Director, BeiGene

Lorenzo Montrasio
Former Senior Scientific Officer, Council of Europe

Paolo Morgese
Head of Public Affairs, Europe, Alliance for Regenerative Medicine

Christine Mossa
Vice President, Global Value & Access, Neuroscience, Ipsen Biopharmaceuticals Canada Inc.

Michael Mueller
Head Of Market Access, Western Europe, Sun Pharma

Neil Mulcock
Vice President, International Government Affairs and Policy, Gilead Sciences

Andrew Mumford
Chief Executive Officer, Initiate Consultancy

Bogdan Muresan
Director, Global HEOR, Astellas Pharma

Katrin Nather
•

Associate Director, Genesis Research Group

Alexander Natz
Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Emilie Neez
Director, Dolon

Claudia Neuber
Head of Global Pricing, Oncology, AstraZeneca

Eric Noehrenberg
Global Vice President, Market Access and Government Affairs, CORCYM

Esther Nzenza, Chief Executive Officer & Founder, DECISIVE CONSULTING LTD

Andrew Olaye
Executive Director, Head of Market Access and Partnership EMEA, Orchard Therapeutics Ltd

Matias Olsen
Senior Manager, Public Affairs & Policy, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

Melvin Olson
Founder, Olson Strategies, Olson Strategies GmbH

Donal O'Sullivan
Global Head, Market Access, Mundipharma

Loubna Ouriaghli
Head of Government Affairs and Policy, Ipsen

Gavin Outteridge
Managing Director, AESARA Europe

Ipek Ozer-Stillman,
Vice President, Global Head, Health Economics, Takeda

Casper Paardekooper
Partner, Vintura, Part of Cencora

Robert Palmer
Head of Market Access, Oncology, Boehringer Ingelheim

Elena Panitti
Global Director, Evidence Valuation and Enablement, Novartis

Michela Pantaleoni
Chief Market Access Officer, Napo Therapeutics

2024 Sponsors

TITLE SPONSOR:
• Lifescience Dynamis

PLATINUM SPONSORS:
• PXA
• Parexel
• Access Infinity
• Alira Health
• Eversana
• Putnam Inizio Company
• Remap
• Valid Insight

GOLD SPONSORS:
• Cube
• Decisive Consulting
• Lyfegen
• Ernst & Young
• Generis Research Group
• Global Pricing Innovations
• MKT XS
• Precision Advisors
• Sentence Partners
•